Search

everythinglearnresearchcommunity

for

Search:↓

Proper medical treatments can control and even reverse female pattern hair loss, but it's important to check for related conditions like excessive male hormone production, especially in severe cases.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

People with PCOS often have skin problems like excessive hair growth, hair loss, acne, and dark patches, which are linked to hormonal and metabolic imbalances.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Hirsutism and acne indicate high androgen levels in women with PCOS, suggesting early treatment can help.

Teen hair loss common in boys, linked to family history and mild symptoms.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

A woman with high testosterone and an adrenal nodule had an ovarian tumor causing her symptoms, which improved after the tumor was removed.

New methods help diagnose skin conditions caused by too much male hormone in women, like acne, hair loss, and excess hair growth.

Leydig cell hyperplasia can cause virilization in postmenopausal women and is treatable with surgery.

Ovarian steroid cell tumors can mimic adrenal hyperplasia, and surgery can normalize hormone levels.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

A Saudi individual initially identified as a girl had a genetic disorder affecting gender development.

A 71-year-old woman developed male-like features due to high testosterone levels caused by a benign ovarian tumor, which was successfully removed by surgery.

Glycated hemoglobin is not as effective as the oral glucose tolerance test for diagnosing blood sugar problems in women with PCOS in Southern Iraq.

Irisin and GIP levels are not linked to BMI in women, regardless of PCOS status.

Postmenopausal virilization can be caused by ovarian hyperthecosis, treatable with surgery.

Multimodal recruitment effectively gathered a diverse group for an online survey on ovulation and menstruation health.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

A new genetic mutation causes severe Leydig cell hypoplasia, affecting sexual development.

Idiopathic hirsutism is the most common cause, followed by PCOS, and insulin resistance should be checked in patients with acanthosis nigricans.

A woman's high testosterone levels were caused by a rare ovarian tumor, not the initially diagnosed condition.

Early hair loss may indicate future prostate issues.

DHT is crucial for urethral formation, and its disruption can affect masculinization and lead to hypospadias.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

New method, hair distribution width (HDW), improves accuracy in diagnosing androgenetic alopecia (AGA).

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.